XML 34 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenue $ 618,968 $ 992,584 $ 421,712
Cost of revenue 252,067 215,533 89,807
Gross profit 366,901 777,051 331,905
Operating expenses:      
Research and development 28,910 24,219 11,580
Selling and marketing 38,918 24,439 14,952
General and administrative 111,074 50,732 15,215
Amortization of intangible assets 6,497 1,708  
Restructuring costs 2,975    
Total operating expenses 188,374 101,098 41,747
Operating (loss) income 178,527 675,953 290,158
Interest and other income, net 5,498 1,347 1,526
Income before income taxes and gain on equity method investment 184,025 677,300 291,684
Provision for income taxes 42,102 174,795 72,532
Income before gain on equity method investment 141,923 502,505 219,152
Equity loss in investee     (488)
Gain (loss) on equity-method investments   3,734 (4,354)
Net income from consolidated operations 141,923 506,239 214,310
Net loss attributable to noncontrolling interests 1,480 1,125  
Net income attributable to Fulgent $ 143,403 $ 507,364 $ 214,310
Net income per common share attributable to Fulgent:      
Basic $ 4.76 $ 17.25 $ 9.44
Diluted $ 4.63 $ 16.38 $ 8.91
Weighted-average common shares:      
Basic 30,097 29,408 22,694
Diluted 30,964 30,976 24,056